Liver Diseases  >>  avadomide (CC-122)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
avadomide (CC-122) / BMS
NCT02323906: Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

Terminated
1b
12
US
CC-122, Sorafenib, Nexavar
Celgene
Carcinoma, Hepatocellular
12/16
12/16

Download Options